The Center for Pediatric Inflammatory Bowel Disease (IBD) at Children’s Hospital of Philadelphia (CHOP) is improving lives through research. With many of the top clinical experts in the field, our research aims to improve the health and wellbeing of children and their families affected by IBD — Crohn’s disease, ulcerative colitis, and indeterminate colitis.
Our research is designed to improve and personalize treatment options, as well as advance the current knowledge of the disease. We are an international leader, not only in the exploration of new medical therapies in the laboratory, but also in the application of these discoveries to real-life situations where their use has the potential to improve children’s lives.
The Center for Pediatric IBD is currently involved in about 40 studies, with nearly 1,500 active patients from around the world, making us the largest research program anywhere for pediatric IBD.
Although the exact cause of the disease is still unknown, the prevention and cure of IBD will result from continuing to vastly improve our understanding of the genetic, immunologic and environmental causes of IBD in at-risk individuals.